Psychomotility and parkinsonism in treatment with neuroleptic drugs.
D014150:Antipsychotic Agents; D002746:Chlorpromazine / Q000627:therapeutic use*; D004565:Electroconvulsive Therapy; D006801:Humans; D001523:Mental Disorders / Q000628:therapy*; D009068:Movement; D010300:Parkinson Disease / Q000209:etiology*; D020734:Parkinsonian Disorders; D011613:Psychotherapy; D012110:Reserpine / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D012110:Reserpine; D002746:Chlorpromazine
CHLORPROMAZINE/therapeutic use; MENTAL DISORDERS/therapy; MOVEMENT; PARALYSIS AGITANS/etiology and pathogenesis; RESERPINE/therapeutic use